Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04865731 · ClinicalTrials.gov registry record · Phase 2
Dermaprazole Cream for Radiation Dermatitis in Head and Neck Cancer
A Phase 2 study, sponsored by The University of Texas Health Science Center at San Antonio.
- Completed
- Registry status
- Phase 2
- Development phase
- 6
- Enrollment target
NCT04865731 is a Phase 2 study that has completed, run by The University of Texas Health Science Center at San Antonio. The registered enrollment target is 6 participants.
The verdict
NCT04865731, a Phase 2 study, has completed, sponsored by The University of Texas Health Science Center at San Antonio.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 6 participants
- Enrollment target
Study Summary
In this study, the study team seek to conduct a pilot clinical study to evaluate the safety and efficacy of a reformulated proton pump inhibitor (PPI) cream (Dermaprazole) in definitive head and neck cancer (HNC) patients.
Interventions
- DRUG Aquaphor
- DRUG Dermaprazole
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2022-06-15 |
| Est. Completion | 2024-06-18 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04865731
The ClinicalTrials.gov registry entry for NCT04865731 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 6 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The University of Texas Health Science Center at San Antonio, which has 378 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Aquaphor is the first listed.
NCT04865731 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04865731 about?
NCT04865731 is a clinical study titled "Dermaprazole Cream for Radiation Dermatitis in Head and Neck Cancer". In this study, the study team seek to conduct a pilot clinical study to evaluate the safety and efficacy of a reformulated proton pump inhibitor (PPI) cream (Dermaprazole) in definitive head and neck cancer (HNC) patients.
What is the current status of trial NCT04865731?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 6 participants. The study started on 2022-06-15. Estimated completion is 2024-06-18.
What interventions are being tested in trial NCT04865731?
The interventions under investigation include: Aquaphor (DRUG), Dermaprazole (DRUG).
Who is sponsoring clinical trial NCT04865731?
This trial is sponsored by The University of Texas Health Science Center at San Antonio, which has 378 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.